glp-1 agonists gastrointestinal side effects constipation diarrhea Exploring the of Receptor Agonist: To Ensure Its Optimal Positioning Managing GLP-1/GIP side effects with

Symptoms can include: dizziness shakiness blurred vision nausea irritability confusion hunger fast heart rate sweating Increased heart rate

London, England: 637649

Preclinical research suggests GLP-1 receptor activation may reduce neuroinflammation, decrease amyloid-beta accumulation, enhance synaptic plasticity, and improve brain glucose metabolism

Both medications carry warnings about thyroid tumors, pancreatitis, and gallbladder problems

There are a number of these medications currently available, some of which include: Semaglutide injection (Ozempic) Semaglutide injection (Wegovy) Semaglutide tablets (Rybelsus) Dulaglutide (Trulicity) Exenatide (Byetta) Exenatide extended-release (Bydureon) Liraglutide (Victoza) Lixisenatide (Adlyxin) Tirzepatide injection (Mounjaro) Source [1] Global GLP-1 receptor agonist market In 2024, the global GLP-1 receptor agonist market size was valued at an estimated USD 53.46 billion and is projected to reach USD 156.71 billion by 2030, with a Compound Annual Growth Rate (CAGR) of 17.46% between 2025 and 2030